
Episode #12
12. Private weight loss clinics
New oral orforglipron GLP1 (marketed in the USA by Lilly as Foundayo) was authorised for use in weight management and type 2 diabetes in August 2026 in the UK, making the UK the first country in Europe to do that. At...


















